Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,073 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer.
Kratochwil C, Flechsig P, Lindner T, Abderrahim L, Altmann A, Mier W, Adeberg S, Rathke H, Röhrich M, Winter H, Plinkert PK, Marme F, Lang M, Kauczor HU, Jäger D, Debus J, Haberkorn U, Giesel FL. Kratochwil C, et al. Among authors: winter h. J Nucl Med. 2019 Jun;60(6):801-805. doi: 10.2967/jnumed.119.227967. Epub 2019 Apr 6. J Nucl Med. 2019. PMID: 30954939 Free PMC article.
Oligoprogressive Non-Small-Cell Lung Cancer under Treatment with PD-(L)1 Inhibitors.
Rheinheimer S, Heussel CP, Mayer P, Gaissmaier L, Bozorgmehr F, Winter H, Herth FJ, Muley T, Liersch S, Bischoff H, Kriegsmann M, El Shafie RA, Stenzinger A, Thomas M, Kauczor HU, Christopoulos P. Rheinheimer S, et al. Among authors: winter h. Cancers (Basel). 2020 Apr 23;12(4):1046. doi: 10.3390/cancers12041046. Cancers (Basel). 2020. PMID: 32340408 Free PMC article.
Neoadjuvant anti-programmed death-1 immunotherapy by pembrolizumab in resectable non-small cell lung cancer: First clinical experience.
Eichhorn F, Klotz LV, Kriegsmann M, Bischoff H, Schneider MA, Muley T, Kriegsmann K, Haberkorn U, Heussel CP, Savai R, Zoernig I, Jaeger D, Thomas M, Hoffmann H, Winter H, Eichhorn ME. Eichhorn F, et al. Among authors: winter h. Lung Cancer. 2021 Mar;153:150-157. doi: 10.1016/j.lungcan.2021.01.018. Epub 2021 Jan 21. Lung Cancer. 2021. PMID: 33529989 Clinical Trial.
Adaptive MR-Guided Stereotactic Radiotherapy is Beneficial for Ablative Treatment of Lung Tumors in High-Risk Locations.
Regnery S, Buchele C, Weykamp F, Pohl M, Hoegen P, Eichkorn T, Held T, Ristau J, Rippke C, König L, Thomas M, Winter H, Adeberg S, Debus J, Klüter S, Hörner-Rieber J. Regnery S, et al. Among authors: winter h. Front Oncol. 2022 Jan 11;11:757031. doi: 10.3389/fonc.2021.757031. eCollection 2021. Front Oncol. 2022. PMID: 35087746 Free PMC article.
High-risk patients with locally advanced non-small cell lung cancer treated with stereotactic body radiation therapy to the peripheral primary combined with conventionally fractionated volumetric arc therapy to the mediastinal lymph nodes.
Eichkorn T, Lischalk JW, Stüwe C, Tonndorf-Martini E, Schubert K, Dinges LA, Regnery S, Bozorgmehr F, König L, Christopoulos P, Hörner-Rieber J, Adeberg S, Herfarth K, Winter H, Thomas M, Rieken S, Debus J, El Shafie RA. Eichkorn T, et al. Among authors: winter h. Front Oncol. 2023 Jan 13;12:1035370. doi: 10.3389/fonc.2022.1035370. eCollection 2022. Front Oncol. 2023. PMID: 36713565 Free PMC article.
Dosimetric comparison of advanced radiotherapy approaches using photon techniques and particle therapy in the postoperative management of thymoma.
Haefner MF, Verma V, Bougatf N, Mielke T, Tonndorf-Martini E, König L, Rwigema JM, Simone CB 2nd, Uhlmann L, Eichhorn F, Winter H, Grosch H, Haberer T, Herfarth K, Debus J, Rieken S. Haefner MF, et al. Among authors: winter h. Acta Oncol. 2018 Dec;57(12):1713-1720. doi: 10.1080/0284186X.2018.1502467. Epub 2018 Sep 28. Acta Oncol. 2018. PMID: 30264630
1,073 results